Nonyem Onujiogu, MD
Gynecologic Oncology · South Bend, INNPI 1124262522
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,305 of the $22,672 with a category attached, or 76.3%. AbbVie accounts for 78.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $17,847 and has fallen 86.5% since, to $2,405 in 2025. Among gynecologic oncology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $708.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$18K
- GSK$2K
- Intuitive Surgical$2K
- Tesaro, Inc.$149
- AstraZeneca$91
- Merck$63
- plus $45 from 3 others
What the payments were for
- Consulting fees$17,30576%
- Travel & lodging$3,30515%
- Food & beverage$1,0595%
- Education$1,0034%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $17,691 |
| GSK | 3 | $2,335 |
| Intuitive Surgical | 5 | $2,298 |
| Tesaro, Inc. | 3 | $149 |
| AstraZeneca | 2 | $91 |
| Merck | 4 | $63 |
| Johnson & Johnson | 1 | $24 |
| Tempus AI, Inc | 1 | $18 |
| Clovis Oncology, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$17,545
- JEMPERLI$2,295
- Da Vinci Surgical System$1,250
- DAVINCI XI$1,000
How this compares
$22,672 in reported general payments places this provider in the 95th percentile of 26 gynecologic oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 19 | $363 |
| Ondansetron Hcl | 25 | $307 |
| Prochlorperazine Maleate | 16 | $167 |
| Olanzapine | 16 | $124 |
| Tramadol Hcl | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in South Bend
- Paul LiuSouth Bend$15K
- Latoya PerrySouth Bend$557
- Sameer SharmaDyer$27K
- Iwona PodzielinskiWarsaw$8K
- Jessica Parker MetterIndianapolis$6K
- Hilary HinshawIndianapolis$5K
- Lisa LandrumIndianapolis$4K
- Scott GoodrichFort Wayne$4K
- Samer SchumanNewburgh$3K
- James DunlopIndianapolis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.